Actualités Seelos Therapeutics Inc - SEEL | Actions NASDAQ | ADVFN

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Seelos Therapeutics Inc (SEEL)
Seelos Therapeutics Inc (SEEL) Actualités

Seelos Therapeutics Inc (SEEL)

1,28

0,00

(0,00%)

Fermé 28 Janvier 10:00PM

Retardé de 15 minutes

1,28

0,00

( 0,00% )

Avant marché: 1:00AM

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form EFFECT - Notice of Effectiveness

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form S-3 - Registration statement under Securities Act of 1933

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

2
3
4
Suivant

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Seelos Therapeutics

SG Issuer Societe Generale

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales